[Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma]. 1998

M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
1st Dept. of Surgery, Tohoku University School of Medicine.

Though SMANCS-Lipiodol suspension has advantages over tumor regression, its disadvantages should also be considered: (1) Anaphylactic reaction due to its high molecular weight. (2) Since it readily destroys the tissue, a smaller dose and repeated administration are required. (3) Due to its low viscosity, it easily enters the arterioles and causes damage even to the extrahepatic organs. When this drug is infused into the left hepatic artery in subsegmental fashion, it enters the neighboring gastric tissues through the communication of the left hepatic and left gastric arteries, and this ultimately causes intractable gastric ulcers. Considering the above facts, this drug should be used carefully.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008299 Maleic Anhydrides Used in copolymerization reactions, in the Diels-Alder(diene)synthesis, in the preparation of resins, pharmaceuticals and agricultural chemicals. It is a powerful irritant and causes burns. 2,5-Furandiones,Maleic Anhydride,2,5 Furandiones,Anhydride, Maleic,Anhydrides, Maleic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D009353 Zinostatin An enediyne that alkylates DNA and RNA like MITOMYCIN does, so it is cytotoxic. Neocarzinostatin
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
May 1988, Cancer,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
January 1992, Cancer chemotherapy and pharmacology,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
November 2012, Anticancer research,
M Suzuki, and K Fukuhara, and M Unno, and K Endoh, and H Takeuchi, and H Kodama, and M Oikawa, and S Matsuno
November 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!